At a glance
ClinicalIndex Comparison RecordN/ACompleted· 10 enrolled
Drug / intervention
International Biophysics AffloVest +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of High Frequency Chest Wall Oscillation Vests on Spirometry Measurements, Comparative Study
In Brief
A clinical study evaluating International Biophysics AffloVest and Hill-Rom Monarch for Cystic Fibrosis and Bronchiectasis. Completed, enrolled 10 participants across 1 site.
Detailed Summary
The impact of high-frequency chest wall oscillation therapy on spirometry values (Forced Expiratory Volume, Forced Vital Capacity, Peak Expiratory Flow, Forced Expiratory Flow and Tidal Volume is investigated during use of several products and comparing to baseline values
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCystic Fibrosis, Bronchiectasis
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedAug 2018
Enrollment StartSep 2018
Primary CompletionSep 2018
Study CompletionJul 2019
TodayJul 2026
First PostedAug 14, 2018
Enrollment StartSep 13, 2018
Primary CompletionSep 21, 2018
Study CompletionJul 2, 2019
TodayJul 2, 2026
Enrollment to primary: 8 daysPosted 7.9 years ago
Interventions
International Biophysics AffloVestdevice
High-frequency chest wall oscillation vest
Hill-Rom Monarchdevice
High-frequency chest wall oscillation vest